Stay updated on Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Systemic sclerosis was added as the disease term and Scleroderma removed where it referred to the same condition.
    Difference
    0.0%
    Check dated 2026-04-02T15:40:58.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Napoli, Italy 80138 was updated to Naples, Italy 80138 in the locations list.
    Difference
    0.0%
    Check dated 2026-03-26T11:44:10.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T04:49:01.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3, limited to version metadata and not affecting study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-03-12T00:29:31.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    A Scleroderma topic tag was added, and a link to the Genetic and Rare Diseases Information Center was added to Resources. These changes improve discoverability and provide an additional information source for patients without altering the study details.
    Difference
    0.1%
    Check dated 2026-02-18T16:39:52.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; deleted the Notice about funding lapse and operating status and the previous Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-11T11:55:53.000Z thumbnail image

Stay in the know with updates to Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.